Robert W. Egan

15.4k total citations · 3 hit papers
183 papers, 10.9k citations indexed

About

Robert W. Egan is a scholar working on Physiology, Molecular Biology and Immunology. According to data from OpenAlex, Robert W. Egan has authored 183 papers receiving a total of 10.9k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Physiology, 70 papers in Molecular Biology and 63 papers in Immunology. Recurrent topics in Robert W. Egan's work include Asthma and respiratory diseases (63 papers), Mast cells and histamine (28 papers) and Receptor Mechanisms and Signaling (27 papers). Robert W. Egan is often cited by papers focused on Asthma and respiratory diseases (63 papers), Mast cells and histamine (28 papers) and Receptor Mechanisms and Signaling (27 papers). Robert W. Egan collaborates with scholars based in United States, United Kingdom and Japan. Robert W. Egan's co-authors include Marvín I. Siegel, M. Motasim Billah, Motasim Billah, F. A. Kuehl, Frederick A. Kuehl, William Kreutner, Ping Wu, Richard W. Chapman, Shelby P. Umland and John A. Hey and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Robert W. Egan

182 papers receiving 10.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Interleukin (IL)-10 Inhibits Nuclear Factor кB (NFкB) Activation in Human Monocytes

1995 594 citations Peng Wang, Ping Wu et al. Journal of Biological Chemistry profile →
Prostaglandins, Arachidonic Acid, and Inflammation

1980 579 citations Robert W. Egan et al. profile →
Mechanism for irreversible self-deactivation of prostaglandin synthetase.

1976 504 citations Robert W. Egan et al. Journal of Biological Chemistry profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Robert W. Egan	3.9k	3.9k	3.3k	1.5k	1.3k	183	10.9k
P. Braquet	3.7k 1.0×	3.5k 0.9×	1.9k 0.6×	1.6k 1.0×	1.1k 0.9×	474	12.1k
K. Frank Austen	4.4k 1.1×	3.0k 0.8×	6.4k 1.9×	1.4k 0.9×	1.7k 1.4×	203	15.1k
Sven‐Erik Dahlén	5.9k 1.5×	3.1k 0.8×	2.8k 0.8×	3.1k 2.0×	2.0k 1.6×	214	12.4k
Hiroyuki Tanaka	2.1k 0.5×	4.5k 1.2×	2.1k 0.6×	907 0.6×	1.7k 1.3×	420	11.3k
Frans P. Nijkamp	4.4k 1.1×	2.0k 0.5×	2.6k 0.8×	2.1k 1.4×	535 0.4×	306	9.3k
Per Hedqvist	4.0k 1.0×	2.7k 0.7×	1.5k 0.4×	1.7k 1.1×	2.0k 1.6×	185	9.8k
Takehiko Yokomizo	2.4k 0.6×	3.3k 0.9×	2.2k 0.7×	646 0.4×	858 0.7×	186	8.2k
Roderick J. Flower	2.0k 0.5×	6.1k 1.6×	4.3k 1.3×	1.5k 1.0×	2.7k 2.2×	135	13.8k
Robert Newton	2.5k 0.6×	4.6k 1.2×	3.6k 1.1×	1.7k 1.1×	1.5k 1.2×	268	13.3k
Babette B. Weksler	2.0k 0.5×	4.4k 1.1×	1.9k 0.6×	1.1k 0.7×	2.1k 1.6×	214	15.5k

Countries citing papers authored by Robert W. Egan

Since Specialization

Citations

This map shows the geographic impact of Robert W. Egan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert W. Egan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert W. Egan more than expected).

Fields of papers citing papers by Robert W. Egan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert W. Egan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert W. Egan. The network helps show where Robert W. Egan may publish in the future.

Co-authorship network of co-authors of Robert W. Egan

This figure shows the co-authorship network connecting the top 25 collaborators of Robert W. Egan. A scholar is included among the top collaborators of Robert W. Egan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert W. Egan. Robert W. Egan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Peng, Ping Wu, Robert W. Egan, & M. Motasim Billah. (2003). Identification and characterization of a new human type 9 cGMP-specific phosphodiesterase splice variant (PDE9A5). Gene. 314. 15–27. 63 indexed citations

Rizzo, Charles A., Richard K. Yang, Scott Greenfeder, et al.. (2002). The IL-5 receptor on human bronchus selectively primes for hyperresponsiveness. Journal of Allergy and Clinical Immunology. 109(3). 404–409. 40 indexed citations

Jia, Yanlin, Robbie L. McLeod, Xin Wang, et al.. (2002). Anandamide induces cough in conscious guinea‐pigs through VR1 receptors. British Journal of Pharmacology. 137(6). 831–836. 65 indexed citations

McLeod, Robbie L., Donald C. Bolser, Yanlin Jia, et al.. (2002). Antitussive Effect of Nociceptin/Orphanin FQ in Experimental Cough Models. Pulmonary Pharmacology & Therapeutics. 15(3). 213–216. 37 indexed citations

Wang, Peng, Ping Wu, Robert W. Egan, & M. Motasim Billah. (2001). Human phosphodiesterase 8A splice variants: cloning, gene organization, and tissue distribution. Gene. 280(1-2). 183–194. 50 indexed citations

McLeod, Robbie L., Leonard E. Parra, Galen Carey, et al.. (2001). Nociceptin inhibits cough in the guinea‐pig by activation of ORL₁ receptors. British Journal of Pharmacology. 132(6). 1175–1178. 84 indexed citations

Minshall, Eleanor M., Robert P. Schleimer, Lisa Cameron, et al.. (1998). Interleukin-5 Expression in the Bone Marrow of Sensitized Balb/c Mice after Allergen Challenge. American Journal of Respiratory and Critical Care Medicine. 158(3). 951–957. 54 indexed citations

Wang, Peng, et al.. (1997). Expression, Purification, and Characterization of Human cAMP-Specific Phosphodiesterase (PDE4) Subtypes A, B, C, and D. Biochemical and Biophysical Research Communications. 234(2). 320–324. 113 indexed citations

Mauser, Peter, John A. Hey, William Kreutner, et al.. (1997). Sch 37224, an Experimental Antiallergy Compound, Inhibits the Neuropeptide Component of Hyperventilation- and Nicotine-Induced Bronchoconstriction in Guinea Pigs. Pharmacology. 54(1). 8–15. 2 indexed citations

10.

Garlisi, Charles G., Angela Falcone, Motasim Billah, Robert W. Egan, & Shelby P. Umland. (1996). T Cells are the Predominant Source of Interleukin-5 but Not Interleukin-4 mRNA Expression in the Lungs of Antigen-Challenged Allergic Mice. American Journal of Respiratory Cell and Molecular Biology. 15(3). 420–428. 27 indexed citations

11.

Mauser, Peter, Xiomara Fernandez, G. K. Adams, et al.. (1995). Effects of an Antibody to Interleukin-5 in a Monkey Model of Asthma. American Journal of Respiratory and Critical Care Medicine. 152(2). 467–472. 254 indexed citations

12.

Kung, T T, Dawn Stelts, Jackie Zurcher, et al.. (1995). Mast Cells Modulate Allergic Pulmonary Eosinophilia in Mice. American Journal of Respiratory Cell and Molecular Biology. 12(4). 404–409. 122 indexed citations

13.

Kung, T T, Dawn Stelts, Jackie Zurcher, et al.. (1995). Involvement of IL-5 in a Murine Model of Allergic Pulmonary Inflammation: Prophylactic and Therapeutic Effect of an Anti-IL-5 Antibody. American Journal of Respiratory Cell and Molecular Biology. 13(3). 360–365. 165 indexed citations

14.

Bolser, Donald C., David J. Blythin, Richard W. Chapman, et al.. (1995). The pharmacology of SCH 50911: a novel, orally-active GABA-beta receptor antagonist.. Journal of Pharmacology and Experimental Therapeutics. 274(3). 1393–1398. 63 indexed citations

15.

Minnicozzi, Michael, et al.. (1995). Polyarginine and Eosinophil-Derived Major Basic Protein Increase Microvascular Permeability Independently of Histamine or Nitric Oxide Release. Microvascular Research. 50(1). 56–70. 11 indexed citations

16.

Wang, Peng, Ping Wu, Marvín I. Siegel, Robert W. Egan, & M. Motasim Billah. (1995). Interleukin (IL)-10 Inhibits Nuclear Factor кB (NFкB) Activation in Human Monocytes. Journal of Biological Chemistry. 270(16). 9558–9563. 594 indexed citations breakdown →

17.

Clark, Mike A., et al.. (1993). Guanine nucleotides and pertussis toxin reduce the affinity of histamine H3 receptors on AtT-20 cells. Inflammation Research. 40(3-4). 129–134. 19 indexed citations

18.

Clark, Mike A., et al.. (1992). High affinity histamine H3 receptors regulate ACTH release by AtT-20 cells. European Journal of Pharmacology. 210(1). 31–35. 17 indexed citations

19.

Hey, John A., M. del Prado, Robert W. Egan, William Kreutner, & Richard W. Chapman. (1992). (R)-α-Methylhistamine augments neural, cholinergic bronchospasm in guinea pigs by histamine H1 receptor activation. European Journal of Pharmacology. 211(3). 421–426. 23 indexed citations

20.

West, Randolph, et al.. (1990). Identification of two H3-histamine receptor subtypes.. Molecular Pharmacology. 38(5). 610–613. 133 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact